zidovudine has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au, JL; Gan, Y; Johnston, J; Lu, J; Mo, Y; Wientjes, MG | 1 |
| Au, JL; Gan, Y; Johnston, J; Mo, Y; Song, S; Wientjes, MG; Xiao, X | 1 |
2 other study(ies) available for zidovudine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Telomere maintenance in telomerase-positive human ovarian SKOV-3 cells cannot be retarded by complete inhibition of telomerase.
Topics: Cells, Cultured; Enzyme Inhibitors; Female; Humans; Oligonucleotides, Antisense; Osteosarcoma; Ovary; Pharynx; Telomerase; Telomere; Zidovudine | 2002 |
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Synergism; Humans; In Situ Hybridization, Fluorescence; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Paclitaxel; Pharyngeal Neoplasms; RNA, Antisense; Telomerase; Telomere; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zidovudine | 2003 |